ClinicalTrials.gg

Drug

Granulocyte Colony-Stimulating Factor clinical trials

studies test it
180
open now
24
in phase 3
29
first study started
1994

Keep track of what changes. Save the Granulocyte Colony-Stimulating Factor studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

180 studies that test it; most in 2004 (13)

Studies that test Granulocyte Colony-Stimulating Factor, by start year
YearStudies
19941
19951
19962
19981
19992
20004
20017
20027
20038
200413
20058
20064
20074
20084
20093
201011
20117
20128
20138
201410
20156
201610
20178
20188
20196
20202
20214
20222
20234
20246
20254
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
34
Phase 2
102
Phase 3
29
Phase 4
18
No phase
17

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 25 · Other 155

M.D. Anderson Cancer Center (10) · Washington University School of Medicine (9) · Genzyme, a Sanofi Company (9) · St. Jude Children's Research Hospital (7) · Northwestern University (6) · Masonic Cancer Center, University of Minnesota (5) · Chinese PLA General Hospital (4) · Post Graduate Institute of Medical Education and Research, Chandigarh (4)

Often tested with

Tested in the same studies.

Filgrastim (140) · Cyclophosphamide (38) · Fludarabine (25) · Plerixafor (24) · Cytarabine (23) · Mesna (15) · Melphalan (14) · Mycophenolic Acid (12)

Studies

Open first, then newest update. How each study uses Granulocyte Colony-Stimulating Factor is read from its arms, and is right about nine times in ten.

Testing it · 180

See all 180 studies that test Granulocyte Colony-Stimulating Factor →

Given in every arm · 142 — Granulocyte Colony-Stimulating Factor is usual care beside what is tested

Showing 20 of 142.

As the comparator · 15 — what is tested is compared with Granulocyte Colony-Stimulating Factor